Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Active, not recruiting
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease
NCT06388083· Phase 2/3· Belite Bio, Inc· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error